Ep. 37 - Ibs Mahmood, MD, CEO, AMO Pharma
Ibraheem Mahmood has an extensive life science and finance background that spans more than 20 years. His experience includes previous roles in Lifescience M&A and Fundraising at Nomura, Lifescience Equity Research at Investec and Business Development and Corporate Venture Capital at Shire Pharmaceuticals. He was co-founder, President and CEO of the clinical operations services company DrugDev, in which he raised over $50m in financing and he sold the business to IQVIA in 2017. Ibraheem studied medicine at the University of Oxford.
You can listen to this episode on Apple Podcast, Spotify, Google Podcast, and Soundcloud or wherever you get your podcast.